Loading clinical trials...
Loading clinical trials...
Obesity ACTION Study in Canada
Conditions
Interventions
No treatment given
Locations
1
Canada
Novo Nordisk Investigational Site
Edmonton, Alberta, Canada
Start Date
August 3, 2017
Primary Completion Date
October 11, 2017
Completion Date
October 11, 2017
Last Updated
July 19, 2019
NCT01143454
NCT07472881
NCT07010757
NCT06989203
NCT06223555
NCT07237750
Lead Sponsor
Novo Nordisk A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions